ARTICLE

Insulin resistance – Not measured in public healthcare

Michel Tagliati

We are now in our 4th year with hundreds of clinical analyses in our practice

 

Research on insulin resistance began mainly in the 1970s when it became possible to measure the presence of insulin in the blood. In conventional clinics, insulin levels are never measured to diagnose diabetes.

 

International convention is to measure fasting blood sugar, average blood sugar, and for pregnant women an oral glucose tolerance test (OGTT).

 

When you gain weight, insulin secretion increases, and this in itself drives further weight gain.

 

In the fat you store, the secretion of inflammatory substances such as interleukins and cytokines begins – the catalyst for all lifestyle-related diseases such as cardiovascular disease, cancer, osteoarthritis, and dementia, to name a few.

Sources

Insulin Resistance and Cancer Risk: An Overview of the Pathogenetic Mechanisms

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3372318/ 

 

Insulin Resistance and Cancer: In Search for a Causal Link

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8540232/ 

 

Diabetes Prevalence in Sweden at Present and Projections for Year 2050

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4664416/pdf/pone.0143084.pdf